Concepedia

Eriko Miyawaki

EM

Statistics

Publications

21

Citations

671

H-Index

16

Active since

2018

Affiliations

Shizuoka Cancer Center(Current)

Juntendo University

Alexion Pharmaceuticals (United States)

Kyoto Prefectural University of Medicine

Toneyama National Hospital

Eriko Miyawaki is an author at Shizuoka Cancer Center specializing in medicine, oncology, and non-small cell lung cancer treatment.

Publications per year

2018–2022

21

Publications

21

Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension

Renato Mantegazza, Gil I. Wolfe, Srikanth Muppidi et al. · Neurology · 2020 · 79 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +9

Propensity score–weighted analysis of chemotherapy after PD-1 inhibitors versus chemotherapy alone in patients with non–small cell lung cancer (WJOG10217L)

Ryoji Kato, Hidetoshi Hayashi, Yasutaka Chiba et al. · Journal for ImmunoTherapy of Cancer · 2020 · 63 citations · Full text

Medicine, Oncology, Pharmacology +15

Optimal Sequence of Local and EGFR-TKI Therapy for EGFR-Mutant Non-Small Cell Lung Cancer With Brain Metastases Stratified by Number of Brain Metastases

Eriko Miyawaki, Hirotsugu Kenmotsu, Keita Mori et al. · International Journal of Radiation Oncology*Biology*Physics · 2019 · 59 citations

Medicine, Oncology, Metastasis +15

Desensitizing Effect of Cancer Cachexia on Immune Checkpoint Inhibitors in Patients With Advanced NSCLC

Taichi Miyawaki, Tateaki Naito, Akihro Kodama et al. · JTO Clinical and Research Reports · 2020 · 58 citations · Full text

Medicine, Immunology, Oncology +17

Eculizumab improves fatigue in refractory generalized myasthenia gravis

Henning Andersen, Renato Mantegazza, Jing Jing Wang et al. · Quality of Life Research · 2019 · 56 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

1–5 of 21